J Kevin Buchi's Net Worth

$8.93 Million

Estimate Recalculated Jun 10, 2024 04:02PM EST

Who is J Kevin Buchi?

J Kevin Buchi has an estimated net worth of $8.93 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, TETRALOGIC PHARMACEUTICALS Corp, ZIOPHARM ONCOLOGY INC, Alexza Pharmaceuticals Inc., Amneal Pharmaceuticals, Inc., Benitec Biopharma Inc., Ampio Pharmaceuticals, Inc., CEPHALON INC, BIOSPECIFICS TECHNOLOGIES CORP, EPIRUS Biopharmaceuticals, Inc., Impax Laboratories, LLC, STEMLINE THERAPEUTICS INC, and ENCYSIVE PHARMACEUTICALS INC.

SEC CIK

J Kevin Buchi's CIK is 0001209726

Past Insider Trading and Trends

2006 was J Kevin Buchi's most active year for acquiring shares with 10 total transactions. J Kevin Buchi's most active month to acquire stocks was the month of November. 2011 was J Kevin Buchi's most active year for disposing of shares, totalling 25 transactions. J Kevin Buchi's most active month to dispose stocks was the month of November. 2013 saw J Kevin Buchi paying a total of $3,174,278.00 for 473,254 shares, this is the most they've acquired in one year. In 2006 J Kevin Buchi cashed out on 90,944 shares for a total of $4,584,803.18, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dicerna Pharmaceuticals Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.67K
$38.25
-$178,474.50
0
Dec 28
Form 4
4.67K
4.67K
Jun 3
Form 4
0
0
Jun 15
Form 4
0
0
Jun 20
Form 4
0
0
Mar 28
Form 4
0
0
Aug 13
Form 3
0
0
No matching records found

TETRALOGIC PHARMACEUTICALS Corp No price found

President & CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.54%
5K
$4.23
$21,147.50
330.71K
Mar 26
Form 4
0
0
Jan 28
Form 4
+1.56%
5K
$5.04
$25,181.00
325.71K
Jan 7
Form 4
+1.58%
5K
$6.01
$30,060.00
320.71K
Dec 9
Form 4
+3.27%
10K
$4.99
$49,900.00
315.71K
Dec 2
Form 4
+3.38%
10K
$4.82
$48,185.00
305.71K
Nov 18
Form 4
+3.50%
10K
$3.93
$39,325.00
295.71K
Nov 11
Form 4
285.71K
$7.00
$1,999,998.00
285.71K
Dec 17
Form 3
0
0
No matching records found

ZIOPHARM ONCOLOGY INC (TCRT) Snapshot price: $2.1371

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
4.17K
4.17K
Mar 4
Form 4
0
0
Oct 8
Form 3
0
0
No matching records found

Alexza Pharmaceuticals Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 21
Form 4
0
0
Jun 23
Form 4
0
0
Jun 10
Form 3
0
0
No matching records found

Amneal Pharmaceuticals, Inc. (AMRX) Snapshot price: $5.37

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+41.19%
76.45K
262.07K
May 10
Form 4
0
0
May 2
Form 4
+75.96%
80.13K
185.62K
May 9 - May 10
Form 4
+50.52%
35.41K
105.49K
May 8 - May 9
Form 4
+193.65%
46.22K
70.08K
May 5 - May 6
Form 4
+37.10%
6.46K
23.87K
May 5 - May 7
Form 4
+54.04%
6.11K
17.41K
May 6 - May 8
Form 4
11.3K
11.3K
May 4 - May 7
Form 3
0
0
No matching records found